Published Mar 26, 2019

Abcuro announces pre-clinical data on new immuno-oncology target

Member News
First in vivo validation of KLRG1 as a new cancer immunotherapy target

Related or similar articles

April 29, 2024

Lab Space Boston: Navigating Opportunities and Challenges

Hello, fellow science enthusiasts! If you're on the hunt for the perfect laboratory space in greater Boston and Cambridge, you've come to the right place. As experts in the field, we at Labshares know a thing or two about navigating the opportunities
Labshares News
October 31, 2018

Labshares Newton Launches Near Capacity and Announces Expansion Plans

Labshares Newton, an office and laboratory incubator for emerging biotechnology and life science companies, announced the launch of its first location in Newton.
Press Releases
August 8, 2018

Harbour BioMed inks $350 million deal for rights to A167

USA-based Harbour BioMed has entered into an exclusive strategic partnership with China’s Sichuan Kelun-Biotech Biopharmaceutical to develop and commercialize A167
Member News